Introducing our 2024 medical research grant recipients

APRIL

This year the Clifford Craig Foundation is proud to announce funding for eight exciting new research projects, with grants totalling $215,000.

They include novel approaches to breast cancer treatments, respiratory infections, multiple sclerosis, diabetes, orthopaedics and palliative care. 

Clifford Craig Chairman Dr John Batten AM said the combination of these newly announced grants, along with the existing research program and scholarships will see the Foundation allocate more than $900,000 to medical research in Tasmania’s North and North-West in 2024. 

“These grants alongside the Foundation’s evolving education initiatives and medical equipment appeals are wonderful examples of how community support is shaping a healthier future for our state,” he said.


2024 medical research grants:

 
 
 

Development of a novel probiotic approach to fight Haemophilus influenzae biofilms in the respiratory tract - Dr Brianna Atto - $76,650

 
 
 

Blood flow restriction as a novel method for rehabilitation after cruciate ligament repair - Dr Laurent Willemot- $37,344

 
 
 

Uncovering the role of the mitochondria gene ACAD10 in metformin action and non-alcoholic fatty liver disease - Dr Darren Henstridge - $24,986

 
 
 

The effect of Mepitel Film on Inter fractional changes in breast area – Ms Bethany Allen - $7,700  

 
 
 

Unveiling the Landscape of Post-Mastectomy Breast Reconstruction in North-North-West Tasmania: A Two-Phase Journey- Dr Rupak Deshpande/Dr Mikko Larsen - $46,475

 
 
 

TAURUS.2 – magneTic brAin stimUlation foR mUltiple Sclerosis – Dr Lauren Giles - $11,000

 
 
 
 

STUCK IN BED: design factors impacting quality of life for patients with limited mobility receiving inpatient palliative care - Dr Maxine Glanger - $9922

 
 

The modification and implementation of an objective tool to assess the carbohydrate counting capability for individuals with type 1 diabetes and their carers in preparation for commencing Continuous Subcutaneous Insulin Infusion (CSII) - Ms Sunita Date - $1103

 
Previous
Previous

Assessing the best approach for breast radiotherapy

Next
Next

A message from the outgoing CEO Peter Milne